Links

  • FDA: Fast-review vouchers to be tied to lower US prices
  • Why FDA rejects drugs (in their own words)
  • Kaiser Health News on prior authorizations.
  • Measles: 1,288 cases in the US this year
  • Impact of ChatGPT on.

Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease

That is the title of my latest paper in JMCP with co-authors Jaehong Kim, Shanshan Wang, Moises Marin, Slaven Sikirica, and Mariam Anderson. The study abstract is below.

Patients with type.